Shenzhen Edge Medical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-218.51	-212.87
Depreciation & Amortization	26	16.94
Other Amortization	2.28	1.93
Loss (Gain) From Sale of Assets	0.01	0.02
Asset Writedown & Restructuring Costs	1.43	-
Loss (Gain) From Sale of Investments	-21.21	-36.97
Stock-Based Compensation	40.03	-13.66
Provision & Write-off of Bad Debts	1.03	0.55
Other Operating Activities	-11.85	-11.77
Change in Accounts Receivable	-11.53	-0.7
Change in Inventory	1.91	-74.14
Change in Accounts Payable	3.42	8.64
Change in Unearned Revenue	-16.24	25.54
Change in Other Net Operating Assets	-21.41	-23.81
Operating Cash Flow	-224.64	-320.31
Capital Expenditures	-26.39	-61.33
Sale of Property, Plant & Equipment	0.06	0.02
Sale (Purchase) of Intangibles	-0.6	-2.27
Investment in Securities	221.46	445.41
Other Investing Activities	1.71	1.91
Investing Cash Flow	196.25	383.73
Long-Term Debt Repaid	-6.97	-7.39
Net Debt Issued (Repaid)	-6.97	-7.39
Other Financing Activities	-0.38	-1.8
Financing Cash Flow	-7.34	-9.18
Foreign Exchange Rate Adjustments	0.23	0.25
Net Cash Flow	-35.5	54.5
Free Cash Flow	-251.03	-381.64
Free Cash Flow Margin	-156.90%	-794.39%
Free Cash Flow Per Share	-0.70	-1.06
Cash Interest Paid	0.86	0.99
Levered Free Cash Flow	-159.7	-
Unlevered Free Cash Flow	-159.16	-
Change in Working Capital	-43.85	-64.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.